Introduction
Gamma-aminobutyric acid (GABA) is the most important inhibitory neurotransmitter in the vertebrate and invertebrate central nervous system (CNS) (Krnjevic, 1974; Roberts, 1986) . GABA has also been found in significant amounts in many mammalian peripheral tissues, although the concentration of GABA in these tissues is Ͻ1% than that observed in cerebral regions. However, the rat oviduct has been found to contain more than twice as much GABA as the brain (Martin del Rio, 1981) .
During the last years, the existence of at least two pharmacologically and functionally distinct populations of GABA receptors has been described in the mammalian brain and in certain peripheral tissues. One of these receptors, termed GABA A , is a plasma membrane structure sensitive to muscimol, isoguvacine and homotaurine acting as agonists, and to bicuculline as an antagonist (Enna and Gallagher, 1983) . This receptor forms a supramolecular complex associated with a chloride channel, and also has binding sites for benzodiazepines and barbiturates (Stephenson, 1988) . In addition, progesterone metabolites with anaesthetic properties enhance the interaction between GABA and its type A receptor (Paul and Purdy, 1992) . In contrast to the GABA A receptor, the GABA B receptor is resistant to bicuculline but is selectively stimulated by the p-chlorophenyl derivative of GABA, baclofen. The GABA B receptor does not seem to be coupled to a chloride channel and is not directly influenced by benzodiazepines or barbiturate (Bowery et al., 1983) . Moreover, there is now increasing evidence for the existence of a third type of GABA receptor, GABA C , which gates Cl -conductance but is not sensitive to conventional GABA A receptor antagonists or modulators, such as bicuculline and pentobarbital (Qian and Dowling, 1993) .
GABAa receptor sites, similar to those described in the CNS, were identified in several peripheral tissues such as the ovary, uterus and placenta (Erdö, 1986) . We have reported the presence of GABA in the rat testis and the stimulatory effect of this neurotransmitter on testosterone production (Ritta et al., 1987) . In addition, we have shown that Leydig cell membranes contain both GABA A and GABA B receptors which may mediate the stimulatory effect of GABA on androgen production in vitro (Ritta et al., 1991) . These observations support a functional role for GABA in the neuroendocrine control of the male gonad. Taking into account recent observations suggesting the involvement of a putative GABAergic receptor in the progesterone-induced acrosome reaction (Wistrom and Meizel, 1993; Blackmore et al., 1994; Roldán et al., 1994) , the present study aimed to investigate the presence of GABA in human semen; the effect of GABA on sperm movement characteristics; and the existence of GABA A receptors in human sperm membranes.
Materials and methods

Reagents
[ 3 H]-muscimol (specific activity 20 Ci/mmol) was purchased from New England Nuclear Co (Boston, MA, USA). GABA, baclofen, isoguvacine and bicuculline were obtained from Sigma Chemical Co (St. Louis, MO, USA). All other reagents were of analytical grade.
Sample collection
Semen samples were obtained from healthy donors after 2 or 3 days of sexual abstinence. Only normal samples according to criteria recommended by World Health Organization (WHO, 1987) were used. Semen specimens were allowed to liquefy for 30 min prior to the swim-up procedure. A highly motile fraction of spermatozoa was recovered after 45 min swim-up in Biggers-Whitten-Whittingham (BWW) medium (Biggers et al., 1971) . Sperm count, motility, velocity and linearity were determined in individual swim-up samples using a Cellsoftô automatic semen analyser (Cryo Resources Ltd, NY, USA).
GABA radioreceptor assay
The method is based on the competitive inhibition of [ 3 H]-muscimol binding to the GABA receptor of cerebellar membranes by GABA present in the sample (Bernasconi et al., 1980; Ritta et al., 1987) . Individual semen samples were centrifuged at 500 g for 10 min. The sperm pellet was washed twice in 50 mM Tris-citrate buffer, pH 7.2 and centrifuged at 500 g for 5 min. The pellet was homogenized by ultrasonication in an appropriate volume of distilled water and centrifuged for 20 min at 12 000 g, at 4°C. Aliquots of these supernatants or seminal plasma were incubated in Eppendorf tubes containing 100 µl of crude cerebellar membranes (70-100 µg of protein), 100 µl of a 40 nM [ 3 H]-muscimol solution and Tris-citrate buffer (50 mM, pH 7.2) to give a final volume of 1 ml. After mixing, the samples were incubated at 4°C for 10 min and the assay terminated by centrifugation at 12 000 g for 10 min at 4°C. The supernatant was discarded and the pellet was rapidly rinsed with 1.5 ml of cold Tris-citrate buffer. After dissolving the pellets in 100 µl of hyamine hydroxide, 10 ml of acidified Aquasol (New England Nuclear Co, Boston, MA, USA) was added and radioactivity was measured by liquid scintillation spectrometry. The lower limit of detection of the method was 12.5 pmol. The intra-assay and inter-assay coefficients of variation were 5 and 12% respectively.
Preparation of sperm membranes
For receptor binding experiments, swim-up fractions from several individuals were pooled and centrifuged at 500 g for 10 min. The sperm pellet was washed twice in 50 mM Tris-citrate buffer, pH 7.4, centrifuged at 500 g for 10 min and immediately frozen and kept at -20°C for at least for 1 week, according to Enna and Snyder (1976) . On the day of the experiment, the cells were thawed and homogenized in 15 volumes of ice-cold 0.32 M sucrose with an Ultraturrax (Janke and Kunkel, IKA, Labortechnik, Germany) at 2500 r.p.m. for 40 s. The homogenate was centrifuged at 1000 g and the supernatant was collected and recentrifuged at 48 000 g for 20 min. The final membrane pellet was washed twice with distilled water, in order to remove endogenous GABA, and resuspended in 50 mM Tris-citrate buffer, pH 7.4 (Ritta et al., 1991) .
[ 3 H]-muscimol binding assay Membrane suspensions (200 µg protein/tube) were incubated in glass tubes containing 10 nM [ 3 H]-muscimol (200 µl final volume) and increasing concentrations of unlabelled muscimol (0.5-200 nM). Nonspecific binding was determined by the addition of a 1000-fold excess of unlabelled muscimol. The reaction was stopped by rapidly filtering the suspensions through glass fibre (Whatman GF/C) under vacuum. The filters were washed three times with ice-cold Tris-citrate buffer. Radioactivity in the filters was measured by liquid scintillation spectrometry at a counting efficiency of 60%.
Assessment of hyperactivation
Individual swim-up spermatozoa were washed with BWW medium, centrifuged at 500 g for 5 min and the sperm pellet was resuspended in capacitating medium (HAM F10, containing 0.05% oestrogenic human serum) to a concentration of 5-20ϫ10 6 spermatozoa/ml. To investigate the possible effect of GABA and muscimol on sperm motility the samples were incubated for 3 h at 37°C, in the presence or absence of the amino acid and the agonist. Detailed sperm motility analysis was performed using a video-micrographic, computer assisted image analysis system (CASA) (CellSoft automatic semen analyser (Cryo Resouces Ltd, NY, USA). A 5 µl aliquot of the sperm suspensions was placed into a 10 µm depth Makler chamber prewarmed at 37°C and CASA analysis was performed. The settings used during analysis were: number of frames analysed per second ϭ 20; frequency ϭ 30 Hz; threshold velocity ϭ 10 µm/sec; minimum sampling for motility ϭ 1 frame; minimum sampling for velocity ϭ 4 frames; pixel scale ϭ 0.688 µm. The parameters analysed were the curvilinear velocity (VCL), straight line velocity (VSL), percentage linearity (% LIN), and the maximum and mean amplitude of lateral head displacement (ALH max ; ALH mean ). Individual results for each trajectory were recorded. Based on studies by Robertson et al. (1988) , the paths of hyperactivated spermatozoa were selected according to the following three criteria (assessed simultaneously): VCL Ͼ80 µm/ s; ALH max Ͼ5 µm and % LIN Ͼ60.
Results
GABA was measured by radioreceptor assay in both seminal plasma and washed spermatozoa from normal donors. As shown in Table I , GABA was detected in both fractions. This was verified as GABA through the observation that it was almost completely (Ͼ85%) degraded by treatment of the samples with the metabolizing enzyme, GABAase (Grahan and Aprison, 1966 ) (data not shown). Specific binding [ 3 H]-muscimol to human sperm membranes increased linearly with protein concentration (50-300 µg), and was maximal at 22°C. Figure 1 shows that maximum binding occurs at 15-20 min of incubation.
[ 3 H]-muscimol binding to human sperm membranes was inhibited by GABA and, to a lesser degree, by the GABA A antagonist bicuculline and by the GABA A agonist, isoguvacine. In contrast, the GABA B agonist, baclofen, was unable to compete with [ 3 H]-muscimol for sperm binding sites (Table II) . Scatchard analysis of [ 3 H]-muscimol binding to sperm membranes yielded a linear plot with a dissociation constant (K d ) of 2.87 nM and maximal binding (B max ) of 398.6 fmol/ mg protein (Figure 2 ). This plot is consistent with a single homogeneous population of binding sites.
Incubation of human spermatozoa obtained by swim-up with 500 µM GABA for 3 h in a capacitating medium resulted in an increased percentage of spermatozoa showing hyperactivated motility only at the highest concentration (Table III) . Exposure of spermatozoa to 5 µM muscimol under the same incubation conditions also caused a significant increment in the percentage of spermatozoa showing hyperactivated motility (Table III) . 
Discussion
The results of this study demonstrate the presence of GABA in human semen; specific GABA A binding sites in sperm plasma membranes and the effect of this amino acid on hyperactivation of spermatozoa capacitated in vitro.
The presence of GABA, and the enzymes responsible for IC 50 values (concentrations producing 50% displacement of the specific binding), given in µM, were determined by probit analysis of three experiments. Each compound was tested in triplicate (concentration range: 10 nM to 10 mM). GABA ϭ γ-aminobutyric acid. its biosynthesis and catabolism, has been shown in numerous peripheral organs of mammals (Erdö, 1985) . In the present study, GABA was found in seminal plasma at concentrations similar to or higher than those reported for human whole blood (Ferkany,1978; Gossman, 1979) and blood plasma (Löscher, 1979; Ferenci, 1983) . Leader et al. (1992) also studied semen from normospermic men and reported GABA concentrations which are higher than those reported here. This discrepancy might be related to the different methods used to evaluate GABA content. However, the radioreceptor assay, which has been widely used to quantify GABA in different tissues, shows acceptable intra-assay and inter-assay coefficients of variation. Moreover, the pre-treatment of samples with GABAase led to the almost complete disappearance of the species measured by the radioreceptor assay in seminal fluid and spermatozoa. Thus, it is highly likely that this species is authentic GABA. Since the enzymes for GABA synthesis were not measured in this study, the source(s) of GABA in spermatozoa remain to be elucidated. GABA could be locally synthesized in spermatozoa or, alternatively, taken up from seminal plasma by an active transport mechanism, as suggested by Aanesen et al. (1995) .
As there is evidence for the occurrence of GABA in the rat testis (Ritta et al., 1987) , epididymis and prostate (Erdö et al., 1983) , and seminal vesicles (Martin del Rio, 1981) , seminal GABA could result from a contribution by any of these tissues.
A role of GABA in some event(s) involved in fertilization, such as the acrosome reaction has been proposed. After contact with female reproductive fluids, spermatozoa undergo a series of events known, in general, as capacitation. These events ultimately lead to the acrosome reaction, which is a specialized form of exocytosis that allows penetration of the egg investments (for review, see Yanagimachi, 1994) . Progesterone has recently emerged as one of a number of putative physiological inducers of the acrosome reaction (Osman et al., 1989; Meizel et al., 1990) . Wistrom and Meizel (1993) have reported that progesterone might exert its effect on capacitated human spermatozoa, at least partially, by interaction with a unique steroid receptor/chloride channel complex which resembles a GABA A receptor. Blackmore et al. (1994) suggested that on human spermatozoa, the cell surface progesterone binding site which mediates its action is different to the steroid binding site on the GABA A receptor. As the progesterone-induced acrosome reaction was inhibited by picrotoxin (a highly specific selective inhibitor of the chloride channel associated with GABA A receptor complex), Simmonds (1980) postulated that a chloride flux was necessary for the progesterone effect to be evident. Moreover, Roldan et al. (1994) demonstrated that the effects triggered by progesterone in mouse spermatozoa were mimicked by GABA and blocked by bicuculline. More recently, Shi et al. (1997) reported that GABA can stimulate the acrosome reaction in human spermatozoa. Calogero et al. (1996) demonstrated that 10 -5 M GABA significantly increased human sperm hyperactivation, while bicuculline antagonized the effect of the neurotransmitter. In addition, the capacitating effect exerted by GABA on ram spermatozoa has been recently reported (de las Heras et al., 1997) . These observations and the description of a GABA A receptor in human spermatozoa by immunocytochemical techniques (Wistrom and Meizel, 1993) , suggest that the effects of GABA might result from activation of the GABA A receptor. In the present study, we provide a biochemical and pharmacological description of GABA A receptors in human sperm membranes. According to our results the K d for [ 3 H]-muscimol calculated by Scatchard analysis was in the low nanomolar range. This is in agreement with values found in other peripheral tissues (Erdö 1986 ).
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These results disagree with those reported by Aanesen et al. (1995) , who failed to identify a GABA receptor on human sperm membranes. This discrepancy could be attributed to the different radioligand used. It is well established that [ 3 H]-GABA is both a substrate for uptake and a ligand for binding assays, while [ 3 H]-muscimol exclusively binds to GABA A receptors (Kanner, 1991) . Moreover, the K d value in the low micromolar range described by Aanesen et al. (1995) is compatible with an uptake mechanism, whereas that in the low nanomolar range, as described in the present report, is usually associated with the receptor site.
The results reported here show the effect of the GABA A receptor agonist muscimol on movement characteristics of human spermatozoa capacitated in vitro, demonstrated by an increase in hyperactivated motility which is commonly associated with the capacitation process. Pharmacological characterization of the muscimol effect deserves further examination. However, the results of binding assays suggest that the increased hyperactivated motility induced by muscimol may be mediated by a GABA A receptor. Although the K d for [ 3 H]-muscimol was in the nanomolar range, the effect of GABA on sperm motility was only evident at high micromolar concentrations. Taking into account the occurrence of an active GABA mechanism in spermatozoa, it is possible that, to some extent, GABA is taken up, resulting in a decreased GABA concentration. On the other hand, since GABA concentrations in the oviduct have been reported to be comparable to those in the brain, the effect described herein on sperm motility, even at micromolar concentrations, could be of physiological relevance.
